Loren Walensky, Lytica Scientific Cofounder, recognized by Nature Biotechnology as One of the World's Top 20 Translational Researchers of 2019

Lytica Therapeutics Receives CARB-X Award For Up To  $16.9 Million To Develop Antimicrobial Peptides To Treat Drug-Resistant Infections

Stapled Antimicrobial Peptide Design, as published in the October Issue of Nature Biotechnology